IMMUNOTHERAPY IN COMBINATION WITH BEHAVIORAL ENRICHMENT IN A CANINE MODEL OF AGING
Alzheimer’s disease (AD) is characterized by cognitive decline and hallmark neuropathology, including β-amyloid (Aβ). Therapeutic strategies for AD are focusing on reducing Aβ. Canines develop Aβ neuropathology and cognitive decline with age similar to AD patients. In previous studies, immunization...
Main Author: | Davis, Paulina R |
---|---|
Format: | Others |
Published: |
UKnowledge
2014
|
Subjects: | |
Online Access: | http://uknowledge.uky.edu/pharmacol_etds/6 http://uknowledge.uky.edu/cgi/viewcontent.cgi?article=1005&context=pharmacol_etds |
Similar Items
-
Quantification of Alzheimer DiseaseAmyloid β Peptide 43 in Human BrainWith a Newly Developed Enzyme-LinkedImmunosorbent Assay (ELISA)
by: Nicklagård, Erik
Published: (2011) -
Connectivity of pathology: The olfactory system as a model for network-driven mechanisms of Alzheimer’s disease pathogenesis
by: Katherine H. Franks, et al.
Published: (2015-12-01) -
The neuroprotective effect of immune serum of adeno-associated virus vaccine containing Aβ1-15 gene on amyloid toxicity
by: Ling-Yun Liu, et al.
Published: (2013-01-01) -
Prevention approaches in a preclinical canine model of Alzheimer’s disease: Benefits and challenges
by: Paulina R. Davis, et al.
Published: (2014-03-01) -
The Concerted Regulation of Intracellular Signaling by Amyloid Precursor Protein and Aβ Peptide
by: Kirouac, Lisa
Published: (2016)